Clinical trial
Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and…
NCT00047632 · InterMune, Industry · Terminated
Key facts
| NCT number | NCT00047632 |
|---|---|
| Title | Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer |
| Official title | Interferon Gamma-1b in Combination With Chemotherapy (Carboplatin/Paclitaxel) for First Line Therapy of Advanced Ovarian or Primary Peritoneal Carcinoma. |
| Lead sponsor | InterMune, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ovarian Carcinoma, Peritoneal Carcinoma |
| Intervention type | Drug |
| Interventions | Interferon gamma-1b |
| Enrollment | 847 |
| Start date | Oct 1, 2001 |
| Completion | Feb 1, 2006 |
| First posted | Oct 11, 2002 |
| Last update posted | Nov 1, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: